Estrella Immunopharma, Inc.ESLANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank40
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-1.79M
↑ 63% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-4.78M
Historical baseline
PeriodValueYoY Change
2025$-1.79M+76.6%
2024$-7.64M+52.5%
2023$-16.07M-1439.3%
2022$-1.04M+27.6%
2021$-1.44M-115.0%
2020$-670820.00-